Maged Abdel Naseer (Maged Abdel-Naseer)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Spectrum Disorder

Ejection Fraction

Mass Spectrometry

Top Venues

Therapeutics and clinical risk management

Neuropsychiatric disease and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Doaa A Mekkawy, Sherif Hamdy, Maged Abdel Naseer, Hatem S Shehata, Ahmed Al Halfawy, Nevin M Shalaby, Ghaydaa A Shehata, Anwar M Ali, Alaa Elmazny, Sandra M Ahmed, Jumana H Ismail, Aml Ibraheim, Hoda M Abdel-Hamid, Rehab Magdy, Younan Kabara Ayoub, Ahmed E Taha, Nahla Merghany, Nourhan M Soliman, Haidy Elshebawy, Samar E S Abdelal, Lobna El-Ghoneimy, Aussan Al-Athwari, Nirmeen A Kishk, Mona A F Nada, Marwa Farghaly, Amr Hassan, Mohamed I Hegazy, Ahmed Abdelalim, Husam S Mourad, Amira Hassouna, Alshimaa S Othman, Tissa Wijeratne
Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study. Brain sciences 12 (1) (2022)
Hend Abdel Ghany, Ahmed Karam-Allah, Ramy Edward, Maged Abdel Naseer, Mohamed I Hegazy
Sensitivity and Specificity of Central Vein Sign as a Diagnostic Biomarker in Egyptian Patients with Multiple Sclerosis. Neuropsychiatric disease and treatment 18 (2022)
Sherif M Hamdy, Maged Abdel Naseer, Hatem S Shehata, Amr Hassan, Alaa Elmazny, Nevin M Shalaby, Noha T Abokrysha, Nirmeen A Kishk, Mona A F Nada, Sandra M Ahmed, Mohamed I Hegazy, Doaa Mekkawy, Husam S Mourad, Ahmed Abdelalim, Thomas Berger
Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach. Therapeutics and clinical risk management 16 (2020)
Sherif M Hamdy, Maged Abdel Naseer, Hatem S Shehata, Nevin M Shalaby, Amr Hassan, Alaa Elmazny, Ehab Shaker, Mona A F Nada, Sandra M Ahmed, Mohamed I Hegazy, Husam S Mourad, Ahmed Abdelalim, Rehab Magdy, Alshimaa S Othman, Doaa A Mekkawy, Nirmeen Adel Kishk
Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era. Therapeutics and clinical risk management 16 (2020)